Methods for Expression and Purification of Immunotoxins
China
201110263529.9
Filed on 2004-08-02
201110263529.9
Filed on 2004-08-02
Methods To Identify Patients At Risk Of Developing Adverse Events During Treatment With Antidepressant Medication
US Application 13/015,068
Filed on 2011-01-27
Filed on 2011-01-27
Methods For Expression and Purification Of Immunotoxins
US Patent 8,921,097
Filed on 2010-11-30
Filed on 2010-11-30
Scopolamine For The Treatment Of Depression And Anxiety
European Patent
10182809.3
Filed on 2006-05-18
10182809.3
Filed on 2006-05-18
Methods for Expression and Purification of Immunotoxins
European Patent
10008896.2
Filed on 2004-08-02
10008896.2
Filed on 2004-08-02
Intranasal Administration Of Ketamine To Treat Depression
Hong Kong
09111706.3
Filed on 2007-03-20
09111706.3
Filed on 2007-03-20
IMMUNOTOXINS FUSION PROTEINS AND MEANS FOR EXPRESSION THEREOF
US Patent 8,217,158
Filed on 2010-03-05
Filed on 2010-03-05
Immunotoxin Fusion Proteins And Means For Expression Thereof
United Kingdom
01935689.8
Filed on 2001-05-18
01935689.8
Filed on 2001-05-18
Immunotoxin Fusion Proteins And Means For Expression Thereof
France
01935689.8
Filed on 2001-05-18
01935689.8
Filed on 2001-05-18
Immunotoxin Fusion Proteins And Means For Expression Thereof
Germany
01935689.8
Filed on 2001-05-18
01935689.8
Filed on 2001-05-18